MétaCan
Menu
Back to cohort
Record W4417001949 · doi:10.1182/blood-2025-1094

Changes in complete blood count (CBC) and white blood cell (WBC) differential associated with overweight and obesity: A patient-level meta-analysis of randomized trials

2025· article· en· W4417001949 on OpenAlexaff
Ella Derkzen, Benjamin Chin‐Yee, Cyrus C. Hsia

Bibliographic record

VenueBlood · 2025
Typearticle
Languageen
FieldMedicine
TopicInflammatory Biomarkers in Disease Prognosis
Canadian institutionsLondon Health Sciences CentreWestern University
Fundersnot available
KeywordsOverweightBody mass indexObesityLeukocytosisComplete blood countWhite blood cellConfoundingClinical trial

Abstract

fetched live from OpenAlex

Abstract Introduction: Obesity is a global public health concern associated with multiple comorbidities and adverse health outcomes. Hematologic changes have been reported in individuals with obesity, including leukocytosis and thrombocytosis, often attributed to increases in pro-inflammatory cytokines. However, the prevalence, magnitude, and clinical significance of these changes remain unclear, with data limited to retrospective studies. It is unknown whether abnormalities in the CBC and WBC differential can be attributed solely to obesity, or if they should prompt further investigation for underlying hematologic disorders. To address this question, we conducted patient-level meta-analysis of clinical trials in overweight and obese patients to characterize changes in the CBC and WBC differential associated with increased body mass index (BMI). Methods: Individual patient data were obtained from five randomized, double-blind, placebo-controlled trials of topiramate in overweight and obese adults from the Yale University Open Data Access program (YODA). Baseline demographics (age, sex, race), clinical (BMI, smoking status), and hematologic (CBC and WBC differential) parameters were pooled at the time of enrolment, before drug intervention. Associations between BMI and each hematologic parameter were examined using multiple linear regression, adjusting for age, sex, and smoking status as potential confounders. Multicollinearity among predictors was evaluated using variance inflation factors (VIF), with all values near 1, indicating minimal correlation between variables and allowing independent estimation of BMI effects. Model assumptions were assessed using residual, Q-Q plots, and Cook's Distance. Regression coefficients from each trial, representing the change in the laboratory value per 1 kg/m2 increase in BMI, were pooled in a two-step meta-analysis to generate summary effects for each parameter. Results: A total of 2,904 overweight and obese individuals (BMI range 26.5-51.4 kg/m²) had available hematologic data at enrolment. The cohort included 650 (22.4%) males and 2,254 (77.6%) females with a mean age of 46 (±11) years. Racial distribution was 2,764 (95.18%) White, 107 (3.68%) Black, 17 (0.59%) Asian, and 16 (0.55%) other. Mean CBC values for both sexes were within standard laboratory reference intervals. In most trial-specific regression models, BMI was positively associated with WBC count, red blood cell (RBC) count, platelet count, absolute lymphocyte count (ALC), and absolute neutrophil count (ANC), and inversely associated with hemoglobin and mean corpuscular volume (MCV). Pooled meta-analysis regression coefficients (per 1 kg/m² BMI) were: WBC +0.06 x10⁹/L; RBC +0.01 x10¹²/L; platelet count +0.84 x10⁹/L; ALC +0.01 x10⁹/L; ANC +0.04 x10⁹/L; hemoglobin -0.04 g/L; MCV –0.05 fL. These coefficients represent the average change in each parameter for every 1 kg/m² increase in BMI; i.e., a 10 kg/m² higher BMI was associated with an estimated WBC increase of 0.6 x10⁹/L, RBC increase of 0.1 x10¹²/L, platelet increase of 8.4 x10⁹/L, ALC increase of 0.1 x10⁹/L, and ANC increase of 0.4 x10⁹/L. Although statistically significant, these BMI-related changes were small in magnitude and most parameters remained within standard reference intervals. Discussion: This large patient-level meta-analysis of overweight and obese adults is the first to comprehensively evaluate hematologic parameters across multiple randomized trials, demonstrating that higher BMI is associated with statistically significant but clinically modest increases in RBC, WBC, and platelet count, and small decreases in hemoglobin and MCV. While these changes may, in rare cases, contribute to values falling above or below standard laboratory reference interval, the magnitude of effect is generally small and unlikely to explain more significant abnormalities. These findings suggest that obesity-related hematologic changes are modest and more substantial deviations should still prompt further evaluation. Hematologists should exercise caution in attributing abnormalities in the CBC and WBC differential solely to elevated BMI, as significant changes are more likely to reflect alternative or concurrent hematologic disorders. Further analyses will evaluate whether changes in BMI within individuals during trials were associated with corresponding changes in hematologic parameters, and these findings will be presented at ASH.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.031
metaresearch head score (Gemma)0.042
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.031
Threshold uncertainty score0.163

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0310.042
Meta-epidemiology (narrow)0.0030.002
Meta-epidemiology (broad)0.0190.055
Bibliometrics0.0040.006
Science and technology studies0.0010.001
Scholarly communication0.0040.002
Open science0.0020.002
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.051
GPT teacher head0.270
Teacher spread0.219 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueBloodSame topicInflammatory Biomarkers in Disease PrognosisFrench-language works237,207